BBB NP Press Releases

National Advertising Division Refers Advertising Claims Made by Creekside Natural Therapeutics to Federal Trade Commission

New York, NY – January 15, 2020 – The National Advertising Division has referred advertising claims made by Creekside Natural Therapeutics, LLC for its Focused Mind Jr. dietary supplement to the Federal Trade Commission for further review, following a challenge by the Council for Responsible Nutrition (“CRN”). NAD is an investigative unit of the advertising industry’s system of self-regulation and is a division of the BBB NP’s self-regulatory and dispute resolution programs. The express claims challenged by CRN appeared in online advertising. Focused Mind Jr. is a dietary supplement for...

Read More

NAD Finds Home Chef’s “More Flexibility than HelloFresh” Claims Supported but Recommends it Modify Certain “Customize It” Claims

New York, NY – Jan. 15, 2020 – The National Advertising Division concluded that Relish Labs, LLC d/b/a Home Chef provided a reasonable basis for its claims that Home Chef meal kit delivery service, with its Customize It feature, offers consumers more flexibility than HelloFresh, following a challenge by Grocery Delivery E-Services, USA d/b/a HelloFresh, a competing meal kit delivery service. However, NAD recommended that the advertiser modify or discontinue other challenged claims for its Home Chef meal kit delivery service. The challenged claims appeared in website, social media,...

Read More

National Advertising Division Refers Advertising Claims Made by International Institute of Health to Federal Trade Commission

New York, NY – January 14, 2020 – The National Advertising Division has referred advertising claims made by International Institute of Health for its Black Gold dietary supplement to the Federal Trade Commission for further review. The advertiser did not respond to NAD’s requests to provide substantiation for its claims. NAD is an investigative unit of the advertising industry’s system of self-regulation and is a division of the BBB NP’s self-regulatory and dispute resolution programs. As part of NAD’s routine monitoring program, NAD requested substantiation for internet advertising claims...

Read More

Certain Advertising Claims for iQ Natural Flooring Permanently Discontinued Following NAD Challenge

New York, NY – Jan. 14, 2020 – Tarkett USA, Inc. stated that it will permanently discontinue certain challenged express claims for its iQ Natural Flooring product in brochures and website advertising, following a challenge before the National Advertising Division by competitor Armstrong Flooring, Inc. NAD is an investigative unit of the advertising industry’s system of self-regulation and is a division of the BBB NP’s self-regulatory and dispute resolution programs. The claims challenged by Armstrong included: Express Claims: “a new plasticizer . . . increases iQ Natural’s total natural and...

Read More

NARB Refers Advertising Claims Made by Neurocore to Federal Trade Commission After Company Fails to Comply with NARB Recommendations

New York, NY – January 13, 2020 – The National Advertising Review Board (NARB) has referred advertising claims made by Neurocore, LLC to the Federal Trade Commission (FTC) for review after the NARB concluded that the company did not comply with NARB’s recommendations. At issue were Neurocore’s quantified outcome claims based on Neurocore’s internal studies and testimonials that claim Neurocore clients have reduced or eliminated the need for medication with ADHD, anxiety, depression, memory problems, migraines, or sleep disorders. The advertising at issue had been reviewed as part of the...

Read More

NAD Inquiry of Tru NIAGEN Dietary Supplement Closes Without Review of Discontinued Product; Advertising Claims Permanently Discontinued

New York, NY – Jan. 9, 2020 – ChromaDex, Inc., the maker of Tru NIAGEN dietary supplement, has advised the National Advertising Division that the advertising claims at issue in a May 1, 2018 inquiry letter were permanently discontinued, and the 250 mg product then-advertised has not been marketed since late 2018, when a 300 mg product entered the market. NAD is an investigative unit of the advertising industry’s system of self-regulation and is a division of the BBB NP’s self-regulatory and dispute resolution programs. As part of NAD’s routine monitoring program, NAD requested substantiation...

Read More